Gunderson Dettmer advised TeneoTwo on the deal. TeneoTwo, a developer of therapeutic antibodies, announced its pending acquisition by AstraZeneca, a bio-pharmaceutical company that focuses on the discovery,...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Ancora Biotech on the deal. Ancora Biotech, a California-based biotechnology company, announced its $60 million Series A financing co-led by Lightspeed Venture Partners and...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Imply Data on the deal. Imply Data, a California-based developer of a full-stack and multi-cloud platform, announced its $100 million Series D financing led...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Lightspeed Venture Partners on the deal while Mintz represented TRIANA Biomedicines. Lightspeed Venture Partners co-led the $110 million...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Neuron23 on the deal. Neuron23, a biotechnology company, announced its $100 million Series C financing led by SoftBank Vision Fund 2. Neuron23 focuses on...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Electra Therapeutics on the deal. Electra Therapeutics, a clinical-stage biotechnology company, announced its $84 million Series B financing co-led...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised Seismic Therapeutic, Inc. on the deal while Gunderson Dettmer represented Lightspeed Venture Partners. Seismic Therapeutic, Inc., a biotechnology company advancing machine learning for...
You must be a Standard 1 Year member to access this content.
Fenwick & West and Wilson Sonsini Goodrich & Rosati advised Metagenomi on the deal while Gunderson Dettmer represented PFM Health Sciences. Metagenomi, a genetic medicines company...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Carto on the deal. Carto, a cloud-native spatial analysis platform, announced its $61 million Series C financing led by...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Alamar Biosciences on the deal. Alamar Biosciences, a precision proteomics company, announced its $80 million Series B financing led...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised NotCo on the deal. NotCo, a food technology company making plant-based milk and meat replacements, wrapped up another...
You must be a Standard 1 Year member to access this content.
